JP Morgan Cazenove today reaffirms its overweight investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and cut its price target to 3200p (from 3300p).
JP Morgan Cazenove today reaffirms its overweight investment rating on Intermediate Capital Group PLC (LON:ICP) and raised its price target to 1590p (from 1400p).